Covered recipient · General Payments record
JOHN T MCADORY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,063.62
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $295.72 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $86.43 | 4 |
| Acerta Pharma LLC | $58.18 | 3 |
| VERTEX PHARMACEUTICALS INCORPORATED | $45.00 | 1 |
| Novo Nordisk AS | $44.91 | 2 |
| DEXCOM, INC. | $23.51 | 1 |
| Amgen Inc. | $20.73 | 1 |
| Lilly USA, LLC | $16.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.73 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117321998 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.25 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105352160 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.10 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104286208 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.83 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105449951 | CMS |
| Dexcom, Inc. | $23.51 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310345 | CMS |
| Lilly USA, LLC | $16.96 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135078673 | CMS |
| Novo Nordisk Inc | $24.00 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096863356 | CMS |
| Novo Nordisk Inc | $20.91 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097060532 | CMS |
| PFIZER INC. | $16.89 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131557631 | CMS |
| PFIZER INC. | $18.34 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131548196 | CMS |
| PFIZER INC. | $22.80 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131518905 | CMS |
| PFIZER INC. | $28.40 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131526215 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $45.00 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105910770 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.